Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Centre Oscar Lambret
Ferring Pharmaceuticals
Ocellaris Pharma, Inc.
NRG Oncology
Astellas Pharma Inc
Dana-Farber Cancer Institute
Actym Therapeutics, Inc.
Institut du Cancer de Montpellier - Val d'Aurelle
Day One Biopharmaceuticals, Inc.
Medical Diagnostic Laboratories, LLC
Bristol-Myers Squibb
G1 Therapeutics, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Mayo Clinic
University of Chicago
Elevation Oncology
Ohio State University Comprehensive Cancer Center